185 filings
Page 4 of 10
8-K
a9o16w
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
924 aymrn
7 Sep 22
Business combination disclosure
5:00pm
425
xd0i7
6 Sep 22
Business combination disclosure
4:33pm
8-K
0gu5 488fwzbw0
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
q31w 1um0a18mi2u
15 Aug 22
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
4:22pm
8-K
xmnthlpu g55oqofxr
25 May 22
Submission of Matters to a Vote of Security Holders
4:57pm
8-K
32cjqt3 czrwo4
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm
8-K
g5fvgcrqhmvpk15
9 May 22
Other Events
8:06am
8-K/A
e3lqe
2 May 22
Financial Statements and Exhibits
1:19pm
8-K
xheinefoo4q50czt1aj
25 Apr 22
Other Events
8:05am
DEFA14A
aobtgva
13 Apr 22
Additional proxy soliciting materials
4:09pm
S-8
camdxrr zros3a5ze69u
23 Mar 22
Registration of securities for employees
4:22pm
8-K
yf2fd
23 Mar 22
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
4:05pm
8-K
ld8 9hons
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
ltis78oyvt 27
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
x8o97bfdjmq
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am